Investor Lists

Series A genomics investors

Updated 7 November 2026

Firms we have watched take part in a Series A round raised by a genomics company in the last two years. Both the stage and the sector are what they did, not what their website says.

See all 85 →The top 25
85investors on the list+20 this week
1,442cheques in 12 months+4% against the market
$17Mmedian round they joined+113% against the market median
92%wrote a cheque in 12 months
49%have led a round

The Top 25

Ordered by cheques observed, never by anything anyone paid for

Deploying now (25)

  1. 1Lightspeed Venture PartnersDeploying nowVC firm · United States1,341$35Mmedian roundNov 2026last seen
  2. 2BpifranceDeploying nowGovernment · France1,151$4.5Mmedian roundOct 2026last seen
  3. 3Founders FundDeploying nowVC firm · United States1,122$15Mmedian roundOct 2026last seen
  4. 48VCDeploying nowVC firm · United States497$23Mmedian roundOct 2026last seen
  5. 5DCVCDeploying nowVC firm · United States431$29Mmedian roundNov 2026last seen
  6. 6RA Capital ManagementDeploying nowPrivate equity · United States395$93Mmedian roundNov 2026last seen
  7. 7NeoDeploying nowAccelerator · United States364$5.5Mmedian roundNov 2026last seen
  8. 8ARCH Venture PartnersDeploying nowVC firm · United States337$74Mmedian roundOct 2026last seen
  9. 9Abstract VenturesDeploying nowVC firm · United States295$13Mmedian roundNov 2026last seen
  10. 10Matrix Partners ChinaDeploying nowVC firm · United States295$16Mmedian roundNov 2026last seen
  11. 11Quiet CapitalDeploying nowVC firm · United States283$17Mmedian roundOct 2026last seen
  12. 12Novo HoldingsDeploying nowVC firm · Denmark203$60Mmedian roundOct 2026last seen
  13. 13Go CapitalDeploying nowVC firm · France167$6.5Mmedian roundSept 2026last seen
  14. 14F-Prime CapitalDeploying nowVC firm · United States162$30Mmedian roundNov 2026last seen
  15. 15InvusDeploying nowPrivate equity · United States148$81Mmedian roundOct 2026last seen
  16. 16OmnesDeploying nowVC firm · France145$15Mmedian roundNov 2026last seen
  17. 17Vivo CapitalDeploying nowPrivate equity · United States140$64Mmedian roundSept 2026last seen
  18. 18Amplify PartnersDeploying nowVC firm · United States139$20Mmedian roundOct 2026last seen
  19. 19Forbion Capital PartnersDeploying nowPrivate equity · Netherlands134$88Mmedian roundOct 2026last seen
  20. 20Future Planet CapitalDeploying nowVC firm · United Kingdom126$3.6Mmedian roundSept 2026last seen
  21. 21CAS StarDeploying nowVC firm · China116$14Mmedian roundNov 2026last seen
  22. 22WndrCoDeploying nowPrivate equity · United States114$15Mmedian roundSept 2026last seen
  23. 23Catalio Capital ManagementDeploying nowVC firm · United States108$73Mmedian roundOct 2026last seen
  24. 24British Business BankDeploying nowCorporate VC · United Kingdom105$6.3Mmedian roundNov 2026last seen
  25. 25Hatteras Venture PartnersDeploying nowVC firm · United States104$20Mmedian roundNov 2026last seen
60 more on this list

All 85 are in the app, with filters for stage, sector and market. A free account shows 10 per search, Pro up to 1,000.

See the whole list →

Reading for founders at Series A

More books for founders and investors on the Reading List.

As an Amazon Associate we earn from qualifying purchases.

Quick answers about series A genomics investors

Who are the most active series A genomics investors?

By cheques observed, the most active are Lightspeed Venture Partners, Bpifrance, Founders Fund, 8VC and DCVC.

How many series A genomics investors are there?

85 are on record. 92% made an investment in the last 12 months and 49% have led a round.

Which stages do series A genomics investors back?

Of the rounds with a named stage in the last 12 months, mostly Series A (25%) and Seed (22%).

How big are the rounds series A genomics investors join?

The typical (median) round among the leading investors here is $20M.

Which sectors do series A genomics investors back most?

In the last 12 months, mostly AI, Biotech and Healthcare.

Which series A genomics investors lead the most rounds?

Lightspeed Venture Partners (83 led), Founders Fund (42 led) and 8VC (26 led).

Where are series A genomics investors based?

Among the most active, most are based in the United States (17), France (3) and the United Kingdom (2).

What have series A genomics investors invested in recently?

Recent rounds include aSand.ai (Series A, Nov 2026, with Wangsu Science & Technology), T-Therapeutics (Series B, Nov 2026, with British Business Bank) and Circularity Fuels (Seed, Nov 2026, with DCVC).

Built from the rounds we watched, refreshed every night. How we count · Report a correction